Biocartis NV - Company & Market Research Reports

Home /
Companies /
Biocartis NV

Biocartis employs approximately 300 people and is headquartered in Mechelen, Belgium. Biocartis develops novel diagnostic technology platforms. The company produces molecular platforms for sample preparation of nucleic acids, amplification, detection, and generation. The company's proprietary MDx Idylla platform is a fully automated, real time system which offers highly-reliable molecular information from any biological sample in virtually any setting. Idylla addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring.

REFINE BY

KEYWORD

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

 Report
February 2025
316 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

Point-of-Care (PoC) Molecular Diagnostics Market by Product (Assays, Kits, Instruments, Software), Application (Respiratory Diseases, HAIs, Cancer, STDs, Hepatitis), Technology (RT-PCR, INAAT), End-user (Clinics, Hospitals, ICUs), and Region - Forecast to 2028

 Report
June 2023
207 Pages
Global

From

€4505EUR$4,950USD£3,862GBP

Point of Care (POC) Molecular Diagnostics - Global Strategic Business Report

 Report
April 2025
597 Pages
Global

From

€5324EUR$5,850USD£4,564GBP

Liquid Biopsy Market by Biomarkers (Cell-free DNA, Circulating Tumor Cells, Circulating Tumor DNA), Sample (Blood Based, Urine Based), Type, Technology, Indication, End-User, Application - Global Forecast 2025-2030

 Report
March 2025
198 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

Hepatitis Viruses Rapid Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
73 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market Analysis, Executive Guides, Customization and COVID-19 Market Opportunity Analysis.

 Report
April 2025
428 Pages
Global

From

€6366EUR$6,995USD£5,458GBP

HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

 Report
December 2023
109 Pages
Global

From

€3640EUR$4,000USD£3,121GBP

Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides

 Report
April 2025
606 Pages
Global

From

€6366EUR$6,995USD£5,458GBP

Diagnostics PCR Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
July 2024
97 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct To Consumer: Forecasts by Application by Channel and by Country with Market Analysis and Executive Guides

 Report
April 2025
446 Pages
Global

From

€6366EUR$6,995USD£5,458GBP

Global COVID-19 Diagnostic Market: Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides

 Report
April 2025
409 Pages
Global

From

€6366EUR$6,995USD£5,458GBP

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization

 Report
April 2025
501 Pages
Global

From

€6366EUR$6,995USD£5,458GBP

Liquid Biopsy Market - Analysis by Biomarker Type (CTCs, ctDNA, EVs, Others), Product (Assay Kits, Instruments and Devices, Services), By Indication By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)

 Report
December 2022
260 Pages
Global

From

€2184EUR$2,400USD£1,873GBP

Syndromic Multiplex Panels Market 2025-2029 - Strategies, Trends and Forecasts by Syndrome (Respiratory, Sepsis, Gi, Other), Place, Product and Country, with Market Analysis and Executive Guides

 Report
April 2025
454 Pages
Global

From

€6366EUR$6,995USD£5,458GBP

Point of Care Molecular Diagnostics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

 Report
April 2023
115 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027

 Report
April 2025
416 Pages
Global

From

€6366EUR$6,995USD£5,458GBP

Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis

 Report
April 2024
496 Pages
Global

From

€6366EUR$6,995USD£5,458GBP

Point-of-Care Molecular Diagnostics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Distribution Deals in Diagnostics 2016 to 2025

 Report
April 2025
250 Pages
Global

From

€3636EUR$3,995USD£3,117GBP

Point-of-Care Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
131 Pages
Global

From

€4323EUR$4,750USD£3,706GBP

127 Results (Page 2 of 7)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.